These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 19200912)

  • 1. Declining breast cancer incidence and decreased HRT use.
    Brewster DH; Sharpe KH; Clark DI; Collins J
    Lancet; 2009 Feb; 373(9662):459-60; author reply 461. PubMed ID: 19200912
    [No Abstract]   [Full Text] [Related]  

  • 2. [Which is the better choice, estrogen or SERMs in postmenopausal women?].
    Shintani M
    Clin Calcium; 2004 Oct; 14(10):105-10. PubMed ID: 15577140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of SERM on breast cancer and cardiovascular disease: making a comparison between raloxifene use and hormone replacement therapy on the risks of the diseases].
    Higuchi T; Mizunuma H
    Clin Calcium; 2004 Oct; 14(10):81-4. PubMed ID: 15577136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drugs can reduce the incidence of breast cancer: now what?
    Wozniak TF; Eppes PG; Wilson CT
    Del Med J; 1999 Sep; 71(9):387-9. PubMed ID: 10584440
    [No Abstract]   [Full Text] [Related]  

  • 5. Risk-benefit profiles of raloxifene for women.
    Stefanick ML
    N Engl J Med; 2006 Jul; 355(2):190-2. PubMed ID: 16837684
    [No Abstract]   [Full Text] [Related]  

  • 6. Raloxifene (Evista) for breast cancer prevention in postmenopausal women.
    Med Lett Drugs Ther; 2006 May; 48(1234):37. PubMed ID: 16685245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective estrogen receptor modulators (SERM's) in postmenopausal women].
    Kleiverda G
    Ned Tijdschr Geneeskd; 1999 Nov; 143(48):2446-7. PubMed ID: 10608980
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on Mobley and Others: importance of assumptions about VTE mortality in modeling the cost-effectiveness of osteoporosis therapies.
    Meadows ES; Stock J; Johnston JA
    Med Decis Making; 2006; 26(6):633-5; author reply 636-7. PubMed ID: 17099202
    [No Abstract]   [Full Text] [Related]  

  • 9. Experts hopeful about designer estrogens. For some women, selective estrogen receptor modulators (SERMs) help prevent breast cancer.
    Runowicz CD
    Health News; 2003 Apr; 9(4):1-2. PubMed ID: 12710388
    [No Abstract]   [Full Text] [Related]  

  • 10. Raloxifene works as well as tamoxifen in preventing invasive breast cancer.
    Mayo Clin Womens Healthsource; 2006 Oct; 10(10):3. PubMed ID: 16977270
    [No Abstract]   [Full Text] [Related]  

  • 11. Breast cancer facts.
    J Okla State Med Assoc; 2012 Oct; 105(10):411-2. PubMed ID: 23316677
    [No Abstract]   [Full Text] [Related]  

  • 12. Chemoprevention of breast cancer: recommendations and rationale.
    Berg AO;
    Am J Nurs; 2003 May; 103(5):107, 109, 111, 113. PubMed ID: 12759615
    [No Abstract]   [Full Text] [Related]  

  • 13. A STARring role for raloxifene?
    Lancet Oncol; 2006 Jun; 7(6):443. PubMed ID: 16750489
    [No Abstract]   [Full Text] [Related]  

  • 14. Declining breast cancer incidence and decreased HRT use.
    Suhrke P; Zahl PH; Maehlen J
    Lancet; 2009 Feb; 373(9662):460-1; author reply 461. PubMed ID: 19200913
    [No Abstract]   [Full Text] [Related]  

  • 15. Raloxifene for the treatment and prevention of breast cancer?
    Pappas SG; Jordan VC
    Expert Rev Anticancer Ther; 2001 Oct; 1(3):334-40. PubMed ID: 12113100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining breast cancer incidence and decreased HRT use.
    Kumle M
    Lancet; 2008 Aug; 372(9639):608-10. PubMed ID: 18722851
    [No Abstract]   [Full Text] [Related]  

  • 17. Differential effects of alternatives to hormone replacement therapy in postmenopausal healthy women.
    Bjarnason NH
    Dan Med Bull; 2005 May; 52(2):64-81. PubMed ID: 16009050
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effects of SERMs on bone health. Raloxifene effects on breast cancer and cardiovascular events].
    Inoue D
    Clin Calcium; 2010 Mar; 20(3):331-8. PubMed ID: 20190362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raloxifene: handle with care.
    Pritchard KI; Levine M; Walley B;
    CMAJ; 2001 Jul; 165(2):151, 153. PubMed ID: 11501451
    [No Abstract]   [Full Text] [Related]  

  • 20. Bone builder vs. breast cancer.
    Johns Hopkins Med Lett Health After 50; 2007 Jan; 18(11):1-2. PubMed ID: 17323491
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.